Nuo Therapeutics, Inc. (AURX)
About Nuo Therapeutics, Inc.
NUO THERAPEUTICS INC NEW
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2017
- $721.0K
- Net income
- -$2.5M
- Total assets
- $1.8M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Nuo Therapeutics, Inc. (AURX) Stock Price
- Reported a net loss of $2.5M in FY2017.
- Trading 68% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Nuo Therapeutics, Inc..
Write a review
Nuo Therapeutics, Inc.: frequently asked questions
Is Nuo Therapeutics, Inc. an American company?
Nuo Therapeutics, Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Nuo Therapeutics, Inc. headquartered?
Nuo Therapeutics, Inc. is headquartered in Houston, Texas, United States.
Is Nuo Therapeutics, Inc. publicly traded?
Yes — Nuo Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol AURX on the OTC.
What does Nuo Therapeutics, Inc. do?
Nuo Therapeutics, Inc. is an American Medical Devices company in the Health & Beauty sector.
